Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein

被引:92
作者
Carr, Simon M. [1 ]
Munro, Shonagh [1 ]
Kessler, Benedikt [2 ]
Oppermann, Udo [3 ]
La Thangue, Nicholas B. [1 ]
机构
[1] Univ Oxford, Dept Clin Pharmacol, Canc Biol Lab, Oxford OX3 7DQ, England
[2] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 7DQ, England
[3] Univ Oxford, Struct Genom Consortium, Div Med Sci, Oxford OX3 7DQ, England
基金
英国惠康基金;
关键词
Cdk; methylation; phosphorylation; pRb; Set7/9; CYCLIN-DEPENDENT KINASES; TUMOR-SUPPRESSOR PROTEIN; CELL-CYCLE; DNA-DAMAGE; MASS-SPECTROMETRY; IN-VITRO; PRB; E2F; ACETYLATION; BINDING;
D O I
10.1038/emboj.2010.311
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
As a critical target for cyclin-dependent kinases (Cdks), the retinoblastoma tumour suppressor protein (pRb) controls early cell cycle progression. We report here a new type of regulation that influences Cdk recognition and phosphorylation of substrate proteins, mediated through the targeted methylation of a critical lysine residue in the Cdk substrate recognition site. In pRb, lysine (K) 810 represents the essential and conserved basic residue (SPXK) required for cyclin/Cdk recognition and phosphorylation. Methylation of K810 by the methyltransferase Set7/9 impedes binding of Cdk and thereby prevents subsequent phosphorylation of the associated serine (S) residue, retaining pRb in the hypophosphorylated growth-suppressing state. Methylation of K810 is under DNA damage control, and methylated K810 impacts on phosphorylation at sites throughout the pRb protein. Set7/9 is required for efficient cell cycle arrest, and significantly, a mutant derivative of pRb that cannot be methylated at K810 exhibits compromised cell cycle arrest. Thus, the regulation of phosphorylation by Cdks reflects the combined interplay with methylation events, and more generally the targeted methylation of a lysine residue within a Cdk-consensus site in pRb represents an important point of control in cell cycle progression. The EMBO Journal (2011) 30, 317-327. doi:10.1038/emboj.2010.311; Published online 30 November 2010
引用
收藏
页码:317 / 327
页数:11
相关论文
共 38 条
[1]
CYCLIN-A AND THE RETINOBLASTOMA GENE-PRODUCT COMPLEX WITH A COMMON TRANSCRIPTION FACTOR [J].
BANDARA, LR ;
ADAMCZEWSKI, JP ;
HUNT, T ;
LATHANGUE, NB .
NATURE, 1991, 352 (6332) :249-251
[2]
Ultra-fast tandem mass spectrometry scanning combined with monolithic column liquid chromatography increases throughput in proteomic analysis [J].
Batycka, Mariola ;
Ingis, Neil F. ;
Cook, Ken ;
Adam, Alex ;
Fraser-Pitt, Douglas ;
Smith, David G. E. ;
Main, Laura ;
Lubben, Anneke ;
Kessler, Benedikt M. .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2006, 20 (14) :2074-2080
[3]
E2F-associated chromatin modifiers and cell cycle control [J].
Blais, Alexandre ;
Dynlacht, Brian D. .
CURRENT OPINION IN CELL BIOLOGY, 2007, 19 (06) :658-662
[4]
Botz J, 1996, MOL CELL BIOL, V16, P3401
[5]
The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases [J].
Brown, NR ;
Noble, MEM ;
Endicott, JA ;
Johnson, LN .
NATURE CELL BIOLOGY, 1999, 1 (07) :438-443
[6]
Acetylation control of the retinoblastoma tumour-suppressor protein [J].
Chan, HM ;
Krstic-Demonacos, M ;
Smith, L ;
Demonacos, C ;
La Thangue, NB .
NATURE CELL BIOLOGY, 2001, 3 (07) :667-674
[7]
Regulation of p53 activity through lysine methylation [J].
Chuikov, S ;
Kurash, JK ;
Wilson, JR ;
Xiao, B ;
Justin, N ;
Ivanov, GS ;
McKinney, K ;
Tempst, P ;
Prives, C ;
Gamblin, SJ ;
Barlev, NA ;
Reinberg, D .
NATURE, 2004, 432 (7015) :353-360
[8]
The retinoblastoma tumour suppressor in development and cancer [J].
Classon, M ;
Harlow, E .
NATURE REVIEWS CANCER, 2002, 2 (12) :910-917
[9]
Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation [J].
ConnellCrowley, L ;
Harper, JW ;
Goodrich, DW .
MOLECULAR BIOLOGY OF THE CELL, 1997, 8 (02) :287-301
[10]
The regulation of E2F by pRB-family proteins [J].
Dyson, N .
GENES & DEVELOPMENT, 1998, 12 (15) :2245-2262